ClinicalTrials.gg
RecruitingNCT06569862PAN-STOPUpdated Jan 15, 2026

Comparison of the Risk of Surgical Site Infections Between Dressings Stopped at Postoperative Day 1 vs Dressings Stopped at Postoperative Day 6+/-1 After Elective Abdominal Surgery

An interventional study of Postoperative day 1 dressing and Postoperative day 6+/-1 dressing in Elective Abdominal Surgery, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-15.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,288
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Surgical Wound Infection with a site in France — 4 open to participants now, 4 under way, 1 of them phase 3. Surgical Wound Infection · France.

Planned enrollment
3rd of 13
1,288 · median 300
Started
2025
with 1 other
No phase
6 of 21
2 open now
Registered
17th of 21
by date
Lead sponsor
3 of 21
Assistance Publique - Hôpitaux de Paris

Among the 21 studies in Surgical Wound Infection with a site in France, this one is the 3rd largest by planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2025, is one of 6 with no phase, and was the 17th registered.

Surgical Wound Infection

747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.

Browse Surgical Wound Infection studies →

Open to participants now

4 of the 21 studies in Surgical Wound Infection with a site in France are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 85 Surgical Wound Infection studies recruiting now, 62 (73%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Surgical Wound Infection with a site in France, or all of them as a file.
02

Study summary

The daily changing of postoperative dressings is a widespread practice, often continuing until the 5th-7th day after surgery. In theory, dressings aim to reduce the risk of superficial surgical site infections (SSIs). However, several studies have suggested that early removal of the dressing does not significantly impact the rate of superficial SSIs, and this approach is now applied in clinical practice by several teams. A Cochrane review indicated that the absence of dressing does not appear to be harmful, though it emphasized the very low level of evidence provided and the need for high-quality randomized controlled trials. In this study, the investigators aim to provide high-level evidence on the effect of stopping dressings from the 1st postoperative day and the lack of impact on the risk of SSIs, to standardize practices and enable recommendations.

03

Conditions studied

  • Elective Abdominal Surgery

Keywords

  • Surgical site infection
  • Dressing
  • Elective abdominal surgery
  • Postoperative care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient of legal age (≥18 years)
  • Scheduled for elective abdominal surgery requiring a skin incision of at least 4 cm long listed below:

All pancreatectomies, All hepatectomies, All splenectomies, All adrenalectomies, All bariatric surgeries, All gastric surgeries, including gastrectomy and reflux surgery, All parietal surgeries; ventral hernia repairs, inguinal or femoral hernia repairs, with or without mesh placement..

All small bowel resections, Laparotomy cholecystectomies, All duodenal surgeries, Right, transverse or left colectomy, by laparotomy or laparoscopy, provided that there is a skin incision for extraction of the surgical specimen, but without the presence or creation of a stoma Proctectomy but without the presence or creation of a stoma

  • Class I or II (clean or clean-contaminated) according to the ALTEMEIER classification
  • Affiliated in a Social Security scheme (beneficiary or entitled person, excluding AME)
  • Have signed an form

Exclusion criteria

Exclusion Criteria:

  • Presence or completion of a stoma
  • Previous abdominal surgery in the month prior to inclusion
  • Emergency surgery
  • Outpatient surgery
  • Closure by biological glue
  • Active bacterial infection at the time of surgery or recent antibiotic therapy (up to 15 days before surgery)
  • \< 500/mm3 at time of surgery
  • Grade B or C cirrhosis ( classification)
  • Pregnancy
  • Breast-feeding
  • Patient under guardianship or curatorship
  • Patient deprived of liberty by judicial or administrative decision
  • Patient unable to perform perioperative care
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Absolute neutrophil count (ANC)

The number of neutrophils, white blood cells that help fight infection, in a given amount of blood. Too few raises the risk of infection.

It is a count, not a percentage of the white cells. Limits are written in units that mean the same: ≥ 1.5 × 10⁹/L is ≥ 1,500 per mm³ (µL). Each lab has its own reference range.

Child-Pugh class

A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,288 participants (estimated)

Study arms

  • Experimental
    Postoperative day 1 dressing

    After removing the dressing on day 1, no dressing change by a nurse is required.

    Procedure: Postoperative day 1 dressing

  • Other
    Postoperative day 6+/-1 dressing

    Daily dressing changes should be performed according to standard nursing procedures until postoperative day 6 (+/-1)

    Procedure: Postoperative day 6+/-1 dressing

Interventions

  • ProcedurePostoperative day 1 dressing

    The patient's dressing will be removed on the first day after surgery, leaving the incision exposed to air, with daily cleaning.

  • ProcedurePostoperative day 6+/-1 dressing

    The patient will have a daily dressing change according to the usual nursing procedures, including saline serum washing, until the sixth day (+/- 1 day) after surgery. This will be done while the patient is in hospital, or at home if discharged before the sixth day.

06

What researchers measure

Primary outcomes

  1. Proportion of superficial surgical site infections (SSI)

    The percentage of superficial surgical site infections (SSI) within the 30 days following surgery, defined according to the criteria set by the Centers for Disease Control and Prevention (CDC).

    Time frame: Day 30 post-surgery

Secondary outcomes

  1. Direct and indirect costs

    Medical-economic impact

    Time frame: Day 30 post-surgery

  2. Rate of repeat surgery

    Time frame: 30 days post-surgery

  3. Rate of unscheduled nursing care

    Time frame: 30 days post-surgery

  4. Percentage of patients who asked for their scars to be covered

    Time frame: 30 days post-surgery

  5. Total length of hospital stay

    Time frame: 30 days post-surgery

  6. Overall morbidity rate according to Clavien-Dindo

    Time frame: 30 days post-surgery

  7. Rate of antibiotic treatment

    Time frame: 30 days post-surgery

  8. Quality of life for patients

    Patient's quality of life on days 6 and 30 post-surgery as assessed using the EuroQol Research Foundation 5 Dimensions Self-Questionnaire (EQ-5D-5L).

    Time frame: Day 6 and Day 30 post-surgery

  9. The incremental cost-effectiveness ratio (ICER)

    The incremental cost-effectiveness ratio (ICER) measures the costs (from the healthcare system perspective) per infection prevented between the intervention and control arms 30 days after inclusion. It is calculated as the difference in average costs between the two arms divided by the difference in average number of infections between them.

    Time frame: 30 days after inclusion

  10. The incremental cost-utility ratio (ICUR)

    The incremental cost-utility ratio (ICUR) assesses the costs (from the healthcare system perspective) per Quality-Adjusted Life Year (QALY) gained between the intervention arm and the control arm 30 days after inclusion. Quality of life is evaluated using the EQ-5D-5L scale (EuroQol Group) at the inclusion visit, discharge from hospital, and at 30 days, covering five dimensions (mobility, stress/anxiety, ability to perform daily activities, autonomy, pain/discomfort). ICUR is calculated as the difference in average costs between the two arms divided by the difference in average QALYs gained between them.

    Time frame: 30 days after inclusion

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The procedures carried out with the French data privacy authority (CNIL, Commission nationale de l'informatique et des libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients. Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 3 months and ending 3 years following article publication. Requests out of these time frame can also be submitted to the sponsor

Access criteria: Researchers who provide a methodologically sound proposal.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Dec 2027, 25 months after the start.

Of 202 non-industry interventional studies with no phase under Surgical Wound Infection, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's planned 25 months is close to that.

Counting every sponsor, half of 209 studies reached it within 24 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2024
First posted
Aug 26, 2024
StartActual
Nov 6, 2025
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Jan 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06569862
Responsible party
Sponsor
First posted
Aug 26, 2024
Start date
Nov 6, 2025
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Jan 15, 2026

Study contacts

Sebastien GAUJOUX, Prof
Contact
sebastien.gaujoux@aphp.fr
0184827972
Stéphanie LE BOT, Mme
Contact
stephanie.lebot@aphp.fr
0184827450

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion